Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial

Published:2024-08 Issue: Volume: Page:
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Modjarrad Kayvon,Scott Paul T,McCauley Melanie,Ober-Shepherd Brittany,Sondergaard Erica,Amare Mihret F,Parikh Ajay P,Omar Badryah,Minutello Ada-Marie,Adhikarla Haritha,Wu Yukun,P Andrey Rojas,Delore Valentine,Mantel Nathalie,Morrison Meshell N,Kourbanova Kamila S,Martinez Melissa E,Guzman Ivelese,Greenleaf Melissa E,Darden Janice M,Koren Michael A,Hamer Melinda J,Lee Christine E,Hutter Jack N,Peel Sheila A,Robb Merlin L,Vangelisti Manuel,Feroldi Emmanuel

Funder

Sanofi Pasteur SA

Publisher

Elsevier BV

Reference28 articles.

1. Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017–2026;Wkly Epidemiol Rec,2017

2. Systematic review: yellow fever control through environmental management mechanisms;Heinz;Trop Med Int Health,2021

3. Yellow fever control: current epidemiology and vaccination strategies;Chen;Trop Dis Travel Med Vaccines,2020

4. Yellow fever: origin, epidemiology, preventive strategies and future prospects;Gianchecchi;Vaccines,2022

5. Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus;Kraemer;Nat Microbiol,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The promising prospects of a new yellow fever vaccine;The Lancet Infectious Diseases;2024-08